United States Antivenom Market by Manufacturers, States, Type and Application, Forecast to 2022

May 2018 | 118 pages | ID: U447223F6E7EN
GlobalInfoResearch

Abstracts

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Scope of the Report:

This report focuses on the Antivenom in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

• CSL Behring
• Merck & Co., Inc.
• BTG Plc
• Pfizer
• Haffkine Bio-Pharmaceutical Corporation
• Rare Disease Therapeutics
• Flynn Pharma
• Vins Bioproducts
• Bharat Serums and Vaccines
• Serum Biotech

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Market Segment by Type, covers

• Polyvalent antivenom
• Monovalent antivenom

Market Segment by Applications, can be divided into

• Retail Pharmacies
• Hospitals
• Others

There are 17 Chapters to deeply display the United States Antivenom market.

Chapter 1, to describe Antivenom Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Antivenom, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Antivenom, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Antivenom market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Antivenom Research Findings and Conclusion, Appendix, methodology and data source.

Contents

1 MARKET OVERVIEW

1.1 Antivenom Introduction
1.2 Market Analysis by Type
  1.2.1 Polyvalent antivenom
  1.2.2 Monovalent antivenom
1.3 Market Analysis by Applications
  1.3.1 Retail Pharmacies
  1.3.2 Hospitals
  1.3.3 Others
1.4 Market Analysis by States
  1.4.1 California Status and Prospect (2012-2022)
  1.4.2 Texas Status and Prospect (2012-2022)
  1.4.3 New York Status and Prospect (2012-2022)
  1.4.4 Florida Status and Prospect (2012-2022)
  1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 CSL Behring
  2.1.1 Profile
  2.1.2 Antivenom Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 CSL Behring News
2.2 Merck & Co., Inc.
  2.2.1 Profile
  2.2.2 Antivenom Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Merck & Co., Inc. News
2.3 BTG Plc
  2.3.1 Profile
  2.3.2 Antivenom Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 BTG Plc News
2.4 Pfizer
  2.4.1 Profile
  2.4.2 Antivenom Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Pfizer News
2.5 Haffkine Bio-Pharmaceutical Corporation
  2.5.1 Profile
  2.5.2 Antivenom Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 Haffkine Bio-Pharmaceutical Corporation News
2.6 Rare Disease Therapeutics
  2.6.1 Profile
  2.6.2 Antivenom Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Rare Disease Therapeutics News
2.7 Flynn Pharma
  2.7.1 Profile
  2.7.2 Antivenom Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Flynn Pharma News
2.8 Vins Bioproducts
  2.8.1 Profile
  2.8.2 Antivenom Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Vins Bioproducts News
2.9 Bharat Serums and Vaccines
  2.9.1 Profile
  2.9.2 Antivenom Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.9.4 Business Overview
  2.9.5 Bharat Serums and Vaccines News
2.10 Serum Biotech
  2.10.1 Profile
  2.10.2 Antivenom Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.10.4 Business Overview
  2.10.5 Serum Biotech News

3 UNITED STATES ANTIVENOM MARKET COMPETITION, BY MANUFACTURER

3.1 United States Antivenom Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Antivenom Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Antivenom Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Antivenom Manufacturer Market Share
  3.4.2 Top 5 Antivenom Manufacturer Market Share
3.5 Market Competition Trend

4 UNITED STATES ANTIVENOM MARKET ANALYSIS BY STATES

4.1 United States Antivenom Sales Market Share by States
4.2 United States Antivenom Sales by States (2012-2017)
4.3 United States Antivenom Revenue (Value) by States (2012-2017)

5 UNITED STATES MARKET SEGMENTATION ANTIVENOM BY TYPE

5.1 United States Antivenom Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 United States Antivenom Sales and Market Share by Type (2012-2017)
  5.1.2 United States Antivenom Revenue and Market Share by Type (2012-2017)
5.2 Polyvalent antivenom Sales Growth and Price
  5.2.1 United States Polyvalent antivenom Sales Growth (2012-2017)
  5.2.2 United States Polyvalent antivenom Price (2012-2017)
5.3 Monovalent antivenom Sales Growth and Price
  5.3.1 United States Monovalent antivenom Sales Growth (2012-2017)
  5.3.2 United States Monovalent antivenom Price (2012-2017)

6 UNITED STATES MARKET SEGMENTATION ANTIVENOM BY APPLICATION

6.1 United States Antivenom Sales Market Share by Application (2012-2017)
6.2 Retail Pharmacies Sales Growth (2012-2017)
6.3 Hospitals Sales Growth (2012-2017)
6.4 Others Sales Growth (2012-2017)

7 CALIFORNIA ANTIVENOM SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 California Antivenom Revenue, Sales and Growth Rate (2012-2017)
7.2 California Antivenom Sales and Market Share by Type
7.3 California Antivenom Sales by Application (2012-2017)

8 NEW YORK ANTIVENOM SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 New York Antivenom Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Antivenom Sales and Market Share by Type
8.3 New York Antivenom Sales by Application (2012-2017)

9 TEXAS ANTIVENOM SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Texas Antivenom Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Antivenom Sales and Market Share by Type
9.3 Texas Antivenom Sales by Application (2012-2017)

10 FLORIDA ANTIVENOM SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

10.1 Florida Antivenom Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Antivenom Sales and Market Share by Type
10.3 Florida Antivenom Sales by Application (2012-2017)

11 ILLINOIS ANTIVENOM SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

11.1 Illinois Antivenom Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Antivenom Sales and Market Share by Type
11.3 Illinois Antivenom Sales by Application (2012-2017)

12 ANTIVENOM MARKET FORECAST (2017-2022)

12.1 United States Antivenom Sales, Revenue and Growth Rate (2017-2022)
12.2 Antivenom Market Forecast by States (2017-2022)
12.3 Antivenom Market Forecast by Type (2017-2022)
12.4 Antivenom Market Forecast by Application (2017-2022)

13 ANTIVENOM MANUFACTURING COST ANALYSIS

13.1 Antivenom Key Raw Materials Analysis
  13.1.1 Key Raw Materials
  13.1.2 Price Trend of Key Raw Materials
  13.1.3 Key Suppliers of Raw Materials
  13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
  13.2.1 Raw Materials
  13.2.2 Labor Cost
  13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Antivenom

14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

14.1 Antivenom Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Antivenom Major Manufacturers in 2016
14.4 Downstream Buyers

15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

15.1 Sales Channel
  15.1.1 Direct Marketing
  15.1.2 Indirect Marketing
  15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES


Figure Antivenom Picture
Table Product Specifications of Antivenom
Figure United States Sales Market Share of Antivenom by Types in 2016
Table Types of Antivenom
Figure Polyvalent antivenom Picture
Table Major Manufacturers of Polyvalent antivenom
Figure Monovalent antivenom Picture
Table Major Manufacturers of Monovalent antivenom
Table United States Antivenom Sales Market Share by Applications in 2016
Table Applications of Antivenom
Figure Retail Pharmacies Picture
Figure Hospitals Picture
Figure Others Picture
Figure California Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Table CSL Behring Basic Information, Manufacturing Base and Competitors
Table CSL Behring Antivenom Type and Applications
Table CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Antivenom Type and Applications
Table Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BTG Plc Basic Information, Manufacturing Base and Competitors
Table BTG Plc Antivenom Type and Applications
Table BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antivenom Type and Applications
Table Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Haffkine Bio-Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Type and Applications
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
Table Rare Disease Therapeutics Antivenom Type and Applications
Table Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Flynn Pharma Basic Information, Manufacturing Base and Competitors
Table Flynn Pharma Antivenom Type and Applications
Table Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vins Bioproducts Basic Information, Manufacturing Base and Competitors
Table Vins Bioproducts Antivenom Type and Applications
Table Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
Table Bharat Serums and Vaccines Antivenom Type and Applications
Table Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Serum Biotech Basic Information, Manufacturing Base and Competitors
Table Serum Biotech Antivenom Type and Applications
Table Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Antivenom Sales by Manufacturer (2016-2017)
Figure United States Antivenom Sales Market Share by Manufacturer in 2016
Figure United States Antivenom Sales Market Share by Manufacturer in 2017
Table United States Antivenom Revenue by Manufacturer (2016-2017)
Figure United States Antivenom Revenue Market Share by Manufacturer in 2015
Figure United States Antivenom Revenue Market Share by Manufacturer in 2016
Table United States Antivenom Price by Manufacturers (2016-2017)
Figure Top 3 Antivenom Manufacturer Market Share in 2016
Figure Top 3 Antivenom Manufacturer Market Share in 2017
Figure Top 5 Antivenom Manufacturer Market Share in 2016
Figure Top 5 Antivenom Manufacturer Market Share in 2017
Figure United States Antivenom Sales and Growth (2012-2017)
Table United States Antivenom Sales by States (2012-2017)
Table United States Antivenom Sales Market Share by States (2012-2017)
Figure United States 2012 Antivenom Sales Market Share by States
Figure United States 2016 Antivenom Sales Market Share by States
Figure United States Antivenom Revenue and Growth (2012-2017)
Table United States Antivenom Revenue by States (2012-2017)
Table United States Antivenom Revenue Market Share by States (2012-2017)
Table United States 2012 Antivenom Revenue Market Share by States
Table United States 2016 Antivenom Revenue Market Share by States
Table United States Antivenom Sales by Type (2012-2017)
Table United States Antivenom Sales Share by Type (2012-2017)
Table United States Antivenom Revenue by Type (2012-2017)
Table United States Antivenom Revenue Share by Type (2012-2017)
Figure United States Polyvalent antivenom Sales Growth (2012-2017)
Figure United States Polyvalent antivenom Price (2012-2017)
Figure United States Monovalent antivenom Sales Growth (2012-2017)
Figure United States Monovalent antivenom Price (2012-2017)
Table United States Antivenom Sales by Application (2012-2017)
Table United States Antivenom Sales Share by Application (2012-2017)
Figure United States Retail Pharmacies Sales Growth (2012-2017)
Figure United States Hospitals Sales Growth (2012-2017)
Figure United States Others Sales Growth (2012-2017)
Figure California Antivenom Revenue and Growth (2012-2017)
Figure California Antivenom Sales and Growth (2012-2017)
Table California Antivenom Sales by Type (2012-2017)
Table California Antivenom Sales Market Share by Type (2012-2017)
Table California Antivenom Sales by Application (2012-2017)
Table California Antivenom Sales Market Share by Application (2012-2017)
Figure New York Antivenom Revenue and Growth (2012-2017)
Figure New York Antivenom Sales and Growth (2012-2017)
Table New York Antivenom Sales by Type (2012-2017)
Table New York Antivenom Sales Market Share by Type (2012-2017)
Table New York Antivenom Sales by Application (2012-2017)
Table New York Antivenom Sales Market Share by Application (2012-2017)
Figure Texas Antivenom Revenue and Growth (2012-2017)
Figure Texas Antivenom Sales and Growth (2012-2017)
Table Texas Antivenom Sales by Type (2012-2017)
Table Texas Antivenom Sales Market Share by Type (2012-2017)
Table Texas Antivenom Sales by Application (2012-2017)
Table Texas Antivenom Sales Market Share by Application (2012-2017)
Figure Florida Antivenom Revenue and Growth (2012-2017)
Figure Florida Antivenom Sales and Growth (2012-2017)
Table Florida Antivenom Sales by Type (2012-2017)
Table Florida Antivenom Sales Market Share by Type (2012-2017)
Table Florida Antivenom Sales by Application (2012-2017)
Table Florida Antivenom Sales Market Share by Application (2012-2017)
Figure Illinois Antivenom Revenue and Growth (2012-2017)
Figure Illinois Antivenom Sales and Growth (2012-2017)
Table Illinois Antivenom Sales by Type (2012-2017)
Table Illinois Antivenom Sales Market Share by Type (2012-2017)
Table Illinois Antivenom Sales by Application (2012-2017)
Table Illinois Antivenom Sales Market Share by Application (2012-2017)
Figure United States Antivenom Sales, Revenue and Growth Rate (2017-2022)
Table United States Antivenom Sales Forecast by States (2017-2022)
Table United States Antivenom Market Share Forecast by States (2017-2022)
Table United States Antivenom Sales Forecast by Type (2017-2022)
Table United States Antivenom Market Share Forecast by Type (2017-2022)
Table United States Antivenom Sales Forecast by Application (2017-2022)
Table United States Antivenom Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antivenom
Figure Manufacturing Process Analysis of Antivenom
Figure Antivenom Industrial Chain Analysis
Table Raw Materials Sources of Antivenom Major Manufacturers in 2016
Table Major Buyers of Antivenom
Table Distributors/Traders/ Dealers List